Literature DB >> 24530822

Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.

Pietro E Cippà1, Ariana Gaspert2, Christoph Etter1, Zehra Guenduez3, Sylvie Ferrari-Lacraz4, Barbara Rüsi3, Thomas Fehr5.   

Abstract

The role of donor HLA-DP-specific antibodies after renal transplantation is controversial, and only preformed HLA-DP-specific antibodies have been shown to mediate rejection. Here we present a case of late humoral rejection mediated by de novo donor HLA-DP-specific antibodies in a non-sensitized recipient. This unique case demonstrates the pathogenic role of de novo anti-DP antibodies and suggests that HLA-DP matching might be relevant for renal transplantation.
Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24530822     DOI: 10.1016/j.humimm.2014.02.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

Review 1.  Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.

Authors:  Andrew L Lobashevsky
Journal:  World J Transplant       Date:  2014-09-24

2.  Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population.

Authors:  Luyanda Kwofie; Ronald Anderson; Helen Steel; Pieter Meyer Wa
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

Review 3.  Clinically relevant interpretation of solid phase assays for HLA antibody.

Authors:  Maria P Bettinotti; Andrea A Zachary; Mary S Leffell
Journal:  Curr Opin Organ Transplant       Date:  2016-08       Impact factor: 2.640

4.  Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report.

Authors:  Seung Hwan Song; Borae G Park; Juhan Lee; Myoung Soo Kim; Yu Seun Kim; Hyon-Suk Kim
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.